Gustavo A. Rosario Benitez

Array ( [id] => 7386391 [patent_doc_number] => 20040029786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Treatment of ulcerative colitis by introducing CEP antigen composition' [patent_app_type] => new [patent_app_number] => 10/437404 [patent_app_country] => US [patent_app_date] => 2003-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11659 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029786.pdf [firstpage_image] =>[orig_patent_app_number] => 10437404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7448443 [patent_doc_number] => 20040009906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Induction of antigen specific immunologic tolerance' [patent_app_type] => new [patent_app_number] => 10/429314 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18625 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009906.pdf [firstpage_image] =>[orig_patent_app_number] => 10429314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362607 [patent_doc_number] => 20040005315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Induction and maintenance of tolerance to composite tissue allografts' [patent_app_type] => new [patent_app_number] => 10/427013 [patent_app_country] => US [patent_app_date] => 2003-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12254 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005315.pdf [firstpage_image] =>[orig_patent_app_number] => 10427013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5084947 [patent_doc_number] => 20070274998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Novel Bispecific Molecules For Use In Therapy And Diagnosis' [patent_app_type] => utility [patent_app_number] => 10/512960 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7913 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20070274998.pdf [firstpage_image] =>[orig_patent_app_number] => 10512960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019405 [patent_doc_number] => 20050221424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Bispecific molecules for use in therapy and diagnosis of immune related and other diseases' [patent_app_type] => utility [patent_app_number] => 10/512630 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7354 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221424.pdf [firstpage_image] =>[orig_patent_app_number] => 10512630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7440101 [patent_doc_number] => 20040009172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Use of anti-TNFalpha antibodies and another drug' [patent_app_type] => new [patent_app_number] => 10/422287 [patent_app_country] => US [patent_app_date] => 2003-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19353 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009172.pdf [firstpage_image] =>[orig_patent_app_number] => 10422287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6864780 [patent_doc_number] => 20030190306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'HLA matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula' [patent_app_type] => new [patent_app_number] => 10/406292 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9239 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190306.pdf [firstpage_image] =>[orig_patent_app_number] => 10406292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770611 [patent_doc_number] => 20030216551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Fully human anti-CD3 monoclonal antibodies' [patent_app_type] => new [patent_app_number] => 10/383247 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4476 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216551.pdf [firstpage_image] =>[orig_patent_app_number] => 10383247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739691 [patent_doc_number] => 20030157060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Production of tcr gamma delta t cells' [patent_app_type] => new [patent_app_number] => 10/239854 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8138 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157060.pdf [firstpage_image] =>[orig_patent_app_number] => 10239854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769908 [patent_doc_number] => 20030215848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/376344 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17140 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215848.pdf [firstpage_image] =>[orig_patent_app_number] => 10376344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314175 [patent_doc_number] => 20040033941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Immunosuppression using piceatannol and a calcineurin inhibitor' [patent_app_type] => new [patent_app_number] => 10/363494 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3530 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033941.pdf [firstpage_image] =>[orig_patent_app_number] => 10363494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769502 [patent_doc_number] => 20030215442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Methods and compositions for the treatment or prevention of immune disorders using combination therapy' [patent_app_type] => new [patent_app_number] => 10/369300 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20962 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215442.pdf [firstpage_image] =>[orig_patent_app_number] => 10369300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 849282 [patent_doc_number] => 07381801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Chimerized GM-CSF antibodies' [patent_app_type] => utility [patent_app_number] => 10/365123 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 8485 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381801.pdf [firstpage_image] =>[orig_patent_app_number] => 10365123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872943 [patent_doc_number] => 20060165689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7' [patent_app_type] => utility [patent_app_number] => 10/514053 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16994 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165689.pdf [firstpage_image] =>[orig_patent_app_number] => 10514053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 296172 [patent_doc_number] => 07541443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Anti-CD4 antibodies' [patent_app_type] => utility [patent_app_number] => 10/353708 [patent_app_country] => US [patent_app_date] => 2003-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 14829 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541443.pdf [firstpage_image] =>[orig_patent_app_number] => 10353708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796397 [patent_doc_number] => 20030175270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Methods of regulating cytokine receptor signaling' [patent_app_type] => new [patent_app_number] => 10/347051 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8707 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175270.pdf [firstpage_image] =>[orig_patent_app_number] => 10347051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796339 [patent_doc_number] => 20030175212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Use of soluble gammadelta T cell receptors for regulating T cell function' [patent_app_type] => new [patent_app_number] => 10/340536 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18045 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175212.pdf [firstpage_image] =>[orig_patent_app_number] => 10340536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7082678 [patent_doc_number] => 20050048058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Antibody against fibroblast growth factor-23' [patent_app_type] => utility [patent_app_number] => 10/500296 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 39049 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048058.pdf [firstpage_image] =>[orig_patent_app_number] => 10500296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872928 [patent_doc_number] => 20060165684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Therapeutic anti-tirc7 antibodies for use in immune related and other diseases' [patent_app_type] => utility [patent_app_number] => 10/513539 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12022 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165684.pdf [firstpage_image] =>[orig_patent_app_number] => 10513539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5661050 [patent_doc_number] => 20060251646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Anti-tirc7 antibodies in therapy of inflammatiory diseases' [patent_app_type] => utility [patent_app_number] => 10/513611 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21671 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20060251646.pdf [firstpage_image] =>[orig_patent_app_number] => 10513611 [rel_patent_id] =>[rel_patent_doc_number] =>)